Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 1 subfamily E member 3 (OR1E3) is classified as a pseudogene in the human genome[5][7]. It belongs to the olfactory receptor (OR) superfamily, which is part of the large and highly diverse family of G protein-coupled receptors (GPCRs) responsible for recognizing odorant molecules and initiating signal transduction that allows for the perception of smell[5][7]. OR1E3, despite occasionally being referred to as a receptor, does not produce a functional protein in most humans and is considered non-functional, although rare reports suggest certain pseudogenes may regain function under special conditions[4]. Most scientific databases (GeneCards, NCBI, HGNC) classify OR1E3 as a "gene/pseudogene" and assign it no defined role as a therapeutic target or disease mediator[2][6][7]. Functional olfactory receptors do play key roles in olfaction and GPCR signaling, but OR1E3 specifically is not associated with drug interactions, biomarker utility, or therapeutic safety concerns. Key considerations: - The primary issue with this target is that it is a pseudogene, not capable of producing a functional protein in most individuals[5][7]. - It is not considered a druggable or therapeutic target. - The multiple names and aliases largely refer to the same non-functional genomic locus. - Researchers should exercise caution to avoid conflating OR1E3 with functional olfactory receptors such as OR51E2, which is a validated and structurally characterized human odorant GPCR[1][3]. Summary: OR1E3 is a non-functional olfactory receptor pseudogene; it should not be considered a therapeutic target, and the abundance of aliases may cause confusion. If a functional human olfactory receptor target is required, do not use OR1E3.
Not applicable (no drugs act on OR1E3)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 1 subfamily E member 3 (OR1E3).